News & Updates

Low use of CVD prevention strategies in people with HIV
Low use of CVD prevention strategies in people with HIV
18 Nov 2022
COVID-19 vaccination poses no risk of herpes zoster infection
COVID-19 vaccination poses no risk of herpes zoster infection
18 Nov 2022

COVID-19 vaccines do not appear to carry any increased risk of developing herpes zoster infection among recipients, a study has reported.

COVID-19 vaccination poses no risk of herpes zoster infection
18 Nov 2022
Moderate dairy intake protects against COVID-19
Moderate dairy intake protects against COVID-19
17 Nov 2022
Joint replacement ERAS program reforms surgical care during pandemic
Joint replacement ERAS program reforms surgical care during pandemic
15 Nov 2022
COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
15 Nov 2022 byPank Jit Sin

COVID-19 infection is associated with faecal microbiota dysbiosis*, especially those that cause more severe disease, says a prominent researcher. However, there is ambiguity as to whether it is a meaningful association or an epiphenomenon**. 

COVID-19 infection affects faecal microbiota and this condition may persist long after recovery from the disease.
15 Nov 2022
Dolutegravir: A better choice for HIV viral suppression in pregnancy?
Dolutegravir: A better choice for HIV viral suppression in pregnancy?
13 Nov 2022 byRoshini Claire Anthony

Among pregnant individuals on antiretroviral therapy (ART) for HIV-1 infection, those on dolutegravir had the greatest viral suppression rates at delivery, a recent US-based observational study showed. However, birth outcomes generally did not differ between dolutegravir recipients and those on various other ART regimens.

Dolutegravir: A better choice for HIV viral suppression in pregnancy?
13 Nov 2022